Sacituzumab govitecan and trastuzumab deruxtecan: two new antibody–drug conjugates in the breast cancer treatment landscape

por Adams, E., Wildiers, H., Neven, P., Punie, K.
Publicado 2021

Sclerosing Lymphocytic Lobulitis Mimicking a Tumor Relapse in a Young Woman with a History of Breast Cancer

por Decraene, J., Van Ongeval, C., Clinckemaillie, G., Wildiers, H.
Publicado 2015

Matrix Metalloproteinase Expression Patterns in Luminal A Type Breast Carcinomas

por Decock, J., Hendrickx, W., Drijkoningen, M., Wildiers, H., Neven, P., Smeets, A., Paridaens, R.
Publicado 2007

The treatment of early breast cancer in women over the age of 70

por Ring, A, Reed, M, Leonard, R, Kunkler, I, Muss, H, Wildiers, H, Fallowfield, L, Jones, A, Coleman, R
Publicado 2011

Digitally supported health care; evaluation approaches to a complex intervention embedded in a tria

por Staines, A, O'Sullivan, B, Davis, P, Ferrara, L, White, C, Degol, L, Corrigan, T, Musolino, N, Wildiers, H, Soubreyan, P
Publicado 2023

Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11

por Wildiers, H, Guetens, G, De Boeck, G, Verbeken, E, Landuyt, B, Landuyt, W, de Bruijn, E A, van Oosterom, A T
Publicado 2003

Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3

por De Cock, L., Heylen, J., Wildiers, A., Punie, K., Smeets, A., Weltens, C., Neven, P., Billen, J., Laenen, A., Wildiers, H.
Publicado 2021

Short-Term Prognostic Index for Breast Cancer: NPI or Lpi

por Van Belle, V., Decock, J., Hendrickx, W., Brouckaert, O., Pintens, S., Moerman, P., Wildiers, H., Paridaens, R., Christiaens, M. R., Van Huffel, S., Neven, P.
Publicado 2010

Current landscape of ESMO/ASCO Global Curriculum adoption and medical oncology recognition: a global survey

por Cufer, T., Kosty, M., Osterlund, P., Jezdic, S., Pyle, D., Awada, A., Close, J., El-Saghir, N., Lordick, F., Rutkowski, P., Tfayli, A., Wildiers, H.
Publicado 2021

A randomized controlled trial of hand/foot-cooling by hilotherapy to prevent oxaliplatin-related peripheral neuropathy in patients with malignancies of the digestive system

por Coolbrandt, A., Tobback, H., Govaerts, R., Vandezande, L., Vinckx, M., Laenen, A., Wildiers, H., Verslype, C., Dekervel, J., Van Herpe, F., Van Cutsem, E.
Publicado 2023

Assessment of potential process quality indicators for systemic treatment of breast cancer in Belgium: a population-based study

por van Walle, L., Punie, K., Van Eycken, E., de Azambuja, E., Wildiers, H., Duhoux, F.P., Vuylsteke, P., Barbeaux, A., Van Damme, N., Verhoeven, D.
Publicado 2021

Ecteinascidin-743: Evidence of Activity in Advanced, Pretreated Soft Tissue and Bone Sarcoma Patients

por Huygh, G., Clement, Paul M. J., Dumez, H., Schöffski, P., Wildiers, H., Selleslach, J., Jimeno, J. M., Wever, I. De, Sciot, R., Duck, L., Van Oosterom, A. T.
Publicado 2006

Cancer and renal insufficiency results of the BIRMA study

por Janus, N, Launay-vacher, V, Byloos, E, Machiels, J-P, Duck, L, Kerger, J, Wynendaele, W, Canon, J-L, Lybaert, W, Nortier, J, Deray, G, Wildiers, H
Publicado 2010

LBA76_PR Expected medium and long term impact of the COVID-19 outbreak in oncology

por Jerusalem, G., Onesti, C.E., Generali, D.G., Harbeck, N., Wildiers, H., Curigliano, G., Campone, M., Tjan-Heijnen, V., Martin, M., Cristofanilli, M., Pusztai, L., Bartsch, R., Peeters, M., Berchem, G., Tagliamento, M., Cortés, J., Ruhstaller, T., Ciruelos, E.M., Rottey, S., Rugo, H.S.
Publicado 2020